CTS vs WST · P/E 22, rev $541.3M vs P/E 35, rev $1.72B
CTS Corporation (CTS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
CTS Corporation (CTS) is a electronic components company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CTS revenue for 2025-12-31 was $541.3M. Net income was $65.3M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CTS currently screens at market cap $1.30B and trailing P/E 22.1.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CTS currently screens at market cap $1.30B and trailing P/E 22.1. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CTS and WST stock pages for the full models.
Not investment advice.